Less than one-tenth of all population-based research into dementia has been directed towards the two-thirds or more of all people with dementia who live in developing parts of the world — thus, the name "10/66".

Part of the Alzheimer's Disease International Network, 10/66 is a group of researchers who encourage active collaboration between research groups in different developing countries and between developed and developing countries. The research projects have included pilot studies to establish a method for diagnosing dementia in populations with very little formal education; qualitative studies to understand the experience of people with dementia and their carers; intervention studies that investigate whether local community health workers can contribute to care by identifying people who need help; and population-based studies to quantify prevalence and incidence in developing countries.

The 10/66 Group is part of Alzheimer's Disease International and is coordinated through Prof. Martin Prince from the Institute of Psychiatry, King's College, London.

This not-for-profit organisation works with the private and public sectors to develop and implement quality yet affordable diagnostic technologies for diseases prevalent in developing countries, including tuberculosis, malaria and sleeping sickness. It also aims to strengthen laboratories and scale up projects to improve new tool uptake in endemic regions. The website provides information about the organisation's programmes and partners, news and a resource centre with free access to documents such as reports and scientific articles.

IASO is an umbrella organisation for 52 national obesity associations across 56 countries. Its mission statement is to "improve global health by promoting the understanding of obesity and weight-related diseases through scientific research and dialogue, whilst encouraging the development of effective policies for their prevention and management."

The organisation is strongly advocacy-based and publishes frequent statements aimed at policymakers on how to tackle obesity. The website also contains detailed data on the global prevalence of obesity. Since obese people are often at high risk for other diseases such as diabetes or cardiovascular disease, the website also outlines these risks, offering links to other relevant associations.

The centre is a WHO collaborating centre for research and training in the control of cardiovascular disease, and also prevention and rehabilitation for patients in the Eastern Mediterranean Region.

The centre strongly advocates evidence-based health policies as the only way to promote health. Its focus on prevention led to the Isfahan Health Heart Programme, a community programme to promote healthier lifestyles to prevent non-communicable diseases.

The school is an international postgraduate centre of excellence, devoted to research, education and training, and consultancy, with a focus on malaria. The website details the courses and programmes it offers, and has comprehensive coverage of all aspects of attending the school. There are extensive links, including health information for travelling abroad.

This non-profit organisation funds and coordinates the development of effective and affordable anti-malarial drugs through public-private partnerships. Partners include public health institutions, academic laboratories and pharmaceutical companies, and the World Health Organization's Roll Back Malaria partnership. The website contains relevant news, information and links relating to its wide-ranging project portfolio.

The IPTi Consortium consists of leading centres of malaria research in Africa, Europe and the United States, and two UN agencies — the World Health Organization and UNICEF. It has developed a comprehensive research and implementation agenda to quickly resolve scientific questions on whether intermittent preventative treatment with malaria drugs is safe and effective for infants. By answering these questions, it aims to move the intervention into policy and practice.

IARC's mission is to undertake research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. It develops strategies at a theoretical level, however, and does not get involved in direct implementation nor contribute to the formulation of policies or legislation. The agency also does not on the whole contribute to research in to cancer treatments.

The agency publishes several key publications on epidemiology (especially of the disease in developing countries), pathology and genetics. To encourage research, the agency offers several fellowships, scholarships and training courses.